Skip to main content

Dihydroxyphenylethylamine (Dopamine), 3,4-[Ring-2,5,6-3H]-, 1mCi (37MBq)

Dihydroxyphenylethylamine (dopamine, DA), tritiated at the ring-2,5,6- position. Dihydroxyphenylethylamine is a neurotransmitter and is the primary endogenous ligand for dopamine receptors.

For research use only. Not for use in diagnostic procedures
Part Number: NET673250UC
Unit Size: 250 µCi
Part Number: NET673001MC
Unit Size: 1 mCi
  • 1mCi quantities of Dihydroxyphenylethylamine (Dopamine), 3,4-[Ring-2,5,6-3H]-, are available for your research. Dihydroxyphenylethylamine binds dopamine receptors, a class of GPCRs in the central nervous system. Dopamine receptors are implicated in motivation, pleasure, cognition, memory, and learning and are potential drug targets for schizophrenia, Parkinson's disease, and a variety of other psychiatric and neurological conditions.

    We offer both agonist and antagonist radioligands for autoradiographic visualization or performing saturation and competition assays to determine receptor expression levels (Bmax), dissociation constants (Kd), association and dissociation rates (kon and koff), and inhibitor constants (Ki) for a variety of receptors. We develop our radioligands to the highest specific activity possible and provide high purity resulting in low non-specific binding products. Each of our ultra-pure radioligands is fully characterized for pharmacological action and validated in receptor binding assays.

    Radiolabeled ligands remain the most sensitive method for probing receptor binding biology; yielding unprecedented sensitivity gives results that technicians and scientists can trust. For over 50 years, Revvity has been a leading supplier of New England Nuclear (NEN) radiochemicals, liquid scintillation cocktails, vials and nuclear counting detection instruments.

    References for NET673:

    1. Schmitt, M., Dehay, B., Bezard, E. and Garcia-Ladona, F. J. (2016), Harnessing the trophic and modulatory potential of statins in a dopaminergic cell line. Synapse, 70: 71–86.
    2. A.L. Auclair, J.C. Martel, M.B. Assié, L. Bardin, P. Heusler, D. Cussac, M. Marien, A. Newman-Tancredi, J.A. O'Connor, R. Depoortère, Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety, In Neuropharmacology, Volume 70, 2013, Pages 338-347.
  • Concentration
    1.0 mCi/mL
    Molecular Weight
    Drug Discovery & Development
    NEN Radiochemicals
    Detection Method
    Label Position
    Specifically Labeled
    Receptor Type
    Shipping Conditions
    Shipped in Dry Ice
    Special Ordering Information
    This is a radioactive product - shipping address must have a license to receive radioactive materials.
    Therapeutic Area
    CNS & Neurologic
    Unit Size
    1 mCi


1-1 of 1 Resources
Calendar Icon Image
2024 Fresh Lot Calendar